SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-17-364606
Filing Date
2017-12-08
Accepted
2017-12-08 11:24:32
Documents
3
Group Members
LINDEN ADVISORS LPLINDEN GP LLCSIU MIN WONG

Document Format Files

Seq Description Document Type Size
1 SC 13G d507264dsc13g.htm SC 13G 78714
2 EX-A d507264dex99a.htm EX-99.A 5549
3 EX-B d507264dex99b.htm EX-99.B 1046
  Complete submission text file 0001193125-17-364606.txt   86853
Mailing Address VICTORIA PLACE, 31 VICTORIA STREET HAMILTON D0 HM10
Business Address VICTORIA PLACE, 31 VICTORIA STREET HAMILTON D0 HM10 441-294-3202
Linden Capital L.P. (Filed by) CIK: 0001349339 (see all company filings)

IRS No.: 980430338 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83614 | Film No.: 171246470
SIC: 2834 Pharmaceutical Preparations